These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19106912)

  • 1. [Augmentation therapy with alpha-1 antitrypsin: 20 year- follow-up of a deficient patient].
    Pujazon MC; Carles P
    Rev Mal Respir; 2008 Nov; 25(9):1136-41. PubMed ID: 19106912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome?
    Abboud RT; Ford GT; Chapman KR
    Treat Respir Med; 2005; 4(1):1-8. PubMed ID: 15725045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of augmentation therapy in alpha-1 antitrypsin deficiency.
    Kueppers F
    Curr Med Res Opin; 2011 Mar; 27(3):579-88. PubMed ID: 21226542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha 1-antitrypsin. Hope on the horizon for emphysema sufferers?
    Schwaiblmair M; Vogelmeier C
    Drugs Aging; 1998 Jun; 12(6):429-40. PubMed ID: 9638392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data.
    Lieberman J
    Chest; 2000 Nov; 118(5):1480-5. PubMed ID: 11083705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of the patients included in the French cohort of patients with emphysema caused by alpha-1 antitrypsin deficiency].
    Thabut G; Mornex JF; Cuvelier A; Padrazzi B; Pison C; Neukirch F; Lafitte JJ; Boczkowski J; Balduyck M; Muir JF; Carles P; Fournier M
    Rev Mal Respir; 2008 Nov; 25(9):1115-22. PubMed ID: 19106908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-1 antitrypsin: now available, but do we need it?
    Russi EW
    Swiss Med Wkly; 2008 Apr; 138(13-14):191-6. PubMed ID: 18389391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress of emphysema in severe alpha 1-antitrypsin deficiency as assessed by annual CT.
    Dirksen A; Friis M; Olesen KP; Skovgaard LT; Sørensen K
    Acta Radiol; 1997 Sep; 38(5):826-32. PubMed ID: 9332238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation therapy in alpha-1 antitrypsin deficiency.
    Heresi GA; Stoller JK
    Expert Opin Biol Ther; 2008 Apr; 8(4):515-26. PubMed ID: 18352854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency.
    Hubbard RC; Crystal RG
    Am J Med; 1988 Jun; 84(6A):52-62. PubMed ID: 3289387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation therapy of alpha-1 antitrypsin deficiency associated emphysema.
    Traclet J; Delaval P; Terrioux P; Mornex JF
    Rev Mal Respir; 2015 Apr; 32(4):435-46. PubMed ID: 25908241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications.
    Chapman KR; Chorostowska-Wynimko J; Koczulla AR; Ferrarotti I; McElvaney NG
    Int J Chron Obstruct Pulmon Dis; 2018; 13():419-432. PubMed ID: 29430176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
    Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG;
    Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α1-Antitrypsin Deficiency.
    Hatipoğlu U; Stoller JK
    Clin Chest Med; 2016 Sep; 37(3):487-504. PubMed ID: 27514595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a Health Management Program on Healthcare Outcomes among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims Analysis.
    Campos MA; Runken MC; Davis AM; Johnson MP; Stone GA; Buikema AR
    Adv Ther; 2018 Apr; 35(4):467-481. PubMed ID: 29616482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF; Miravitlles M
    Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-1 Antitrypsin Deficiency and Pregnancy.
    Gaeckle NT; Stephenson L; Reilkoff RA
    COPD; 2020 Jun; 17(3):326-332. PubMed ID: 32308050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-1-Antitrypsin Deficiency: Disease Management and Learning from Studies.
    Greulich T
    COPD; 2017 Mar; 14(sup1):S8-S11. PubMed ID: 28306355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: enough is enough.
    Balbi B; Ferrarotti I; Miravitlles M
    Eur Respir J; 2016 Jan; 47(1):35-8. PubMed ID: 26721962
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative disease progression model of α-1 proteinase inhibitor therapy on computed tomography lung density in patients with α-1 antitrypsin deficiency.
    Tortorici MA; Rogers JA; Vit O; Bexon M; Sandhaus RA; Burdon J; Chorostowska-Wynimko J; Thompson P; Stocks J; McElvaney NG; Chapman KR; Edelman JM
    Br J Clin Pharmacol; 2017 Nov; 83(11):2386-2397. PubMed ID: 28662542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.